CIK 0001662579
- Non-accelerated filer
- Smaller reporting company
C4 Therapeutics, Inc.
Sign in to watch- Ticker
- CCCC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 475617627
- Phone
- +1 617-231-0700
- Business address
- 490 ARSENAL WAY, SUITE 120, WATERTOWN, MA, 02472
- 4/A Shares withheld for taxes Chief Medical Officer gave up 1,102 shares (to pay taxes)
- 4/A Shares withheld for taxes Chief Business Officer gave up 1,102 shares (to pay taxes)
- 4 Option exercise Chief Legal Officer acquired 3,750 shares (option exercise)
- 4 Option exercise Chief Medical Officer acquired 3,750 shares (option exercise)
- 4 Option exercise Chief People Officer acquired 3,750 shares (option exercise)
- 4 Option exercise Chief Scientific Officer acquired 3,750 shares (option exercise)
- 4 Option exercise Chief Financial Officer acquired 3,750 shares (option exercise)
- 4 Option exercise Chief Business Officer acquired 3,750 shares (option exercise)
- 4 Option exercise President & CEO acquired 12,500 shares (option exercise)
- 4 Option exercise Chief Scientific Officer acquired 28,084 shares (option exercise)
- 4 Open-market buy President & CEO bought 10,000 shares at $8.40 ($84,000)
- 4 Grant or award Director acquired 379 shares (grant or award)
- 4 Grant or award Director acquired 388 shares (grant or award)
- 4 Grant or award Director acquired 341 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 10 of 15 · 296 filings